About IntegReview IRB
IntegReview IRB is a Healthcare company based in Austin (United States) founded in 1999 by Lynn A Meyer, and was acquired by Advarra in November 2020. Clinical research services are provided to the biopharma sector. Its chief executive, as recorded, is Melissa Meyer. IntegReview IRB offers products and services including CIRBI, OnCore, Clinical Conductor, and eReg. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.
Company details
IntegReview IRB was established in 1999 in Austin, United States, as a provider of clinical research services focused on the biopharmaceutical sector. Institutional review board functions are handled, including protocol assessments and ethical oversight for trials. Operations support biopharma clients through compliance and regulatory guidance. The company is led by founder Lynn A. Meyer and CEO Melissa Meyer, with activities centered in the U.S.
- Headquarters Austin, United States
- Founders Lynn A Meyer
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website integreview.com
- Social LinkedIn Facebook
- Acquired by Advarra (Nov 2020)
Products & Services of IntegReview IRB
IntegReview IRB offers a comprehensive portfolio of products and services, including CIRBI, OnCore, Clinical Conductor, and eReg.
Platform for real-time IRB review and document management.
System for managing clinical trial operations and data.
Tool for regulatory compliance in clinical research.
Platform for electronic consent and regulatory processes.
Investors in IntegReview IRB
IntegReview IRB has secured backing from 1 investor. Prominent investors backing the company include Advarra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global research compliance services including IRB and consulting are provided. | 2017 | advarra.com | Columbia, United States |
Investor details for IntegReview IRB
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of IntegReview IRB
2 people are tracked at IntegReview IRB (2 in leadership).
| Name | Role | Group |
|---|---|---|
Lynn A Meyer | Founder | Leadership |
Melissa Meyer | CEO | Leadership |
Complete people profiles for IntegReview IRB
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of IntegReview IRB
2 dated milestones of IntegReview IRB across 21 years, from founding to its latest funding, stage changes and deals.
- Founded IntegReview IRB is founded.
- Exit Acquired by Advarra.
Competitors of IntegReview IRB
IntegReview IRB has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. |
Detailed competitors of IntegReview IRB
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IntegReview IRB
Websites that share an audience with IntegReview IRB (integreview.com).
Websites whose visitors overlap most with IntegReview IRB. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cgirb.com | 62% | View details | |||
| quorumreview.com | 60% | View details | |||
| wirb.com | 49% | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as IntegReview IRB (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Integreview Irb
Complete news archive for IntegReview IRB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IntegReview IRB
IntegReview IRB was founded in 1999.
IntegReview IRB is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Melissa Meyer is the CEO of IntegReview IRB, as recorded in our data.
IntegReview IRB was established in 1999 in Austin, United States, as a provider of clinical research services focused on the biopharmaceutical sector. Institutional review board functions are handled, including protocol assessments and ethical oversight for trials. Operations support biopharma clients through compliance and regulatory guidance. The company is led by founder Lynn A. Meyer and CEO Melissa Meyer, with activities centered in the U.S.
IntegReview IRB's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
IntegReview IRB offers CIRBI, OnCore, Clinical Conductor, and eReg.
IntegReview IRB has 1 investor. Key investors include Advarra.
Yes. IntegReview IRB was acquired by Advarra in November 2020.